Jiri Beran

Summary

Country: Czech Republic

Publications

  1. pmc Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Jiri Beran
    The Vaccination and Travel Medicine Center, Poliklinika II, Bratri Stefanu 895, Hradec Kralove 500 03, Czech Republic
    BMC Infect Dis 13:224. 2013
  2. pmc Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop
    N Mühlberger
    Institute of Tropical Medicine, Humboldt University, Berlin, Germany
    Malar J 3:5. 2004
  3. pmc The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 6:114. 2007
  4. pmc Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop
    Ole Wichmann
    Institute of Tropical Medicine, Charite, Humboldt University, Berlin, Germany
    Malar J 2:17. 2003
  5. doi request reprint Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial
    Jiri Beran
    The Vaccination and Travel Medicine Center, University Hospital, 500 03 Hradec Králové, Czech Republic
    J Infect Dis 200:1861-9. 2009
  6. pmc Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
    Jiri Beran
    Vaccination and Travel Medicine Centre, Poliklinika II, Hradec Kralove, Czech Republic
    Hum Vaccin 6:578-84. 2010
  7. ncbi request reprint Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients
    Jiri Beran
    School of Medicine and University Hospital, Department of Infectious Diseases, Hradec Kralove, Czech Republic
    Expert Opin Biol Ther 8:235-47. 2008
  8. ncbi request reprint [The importance of the second generation adjuvanted systems in "new" vaccines]
    Jiri Beran
    Centre of vaccination and travel medicine, Hradec Kralove, Czech Republic
    Klin Mikrobiol Infekc Lek 14:5-12. 2008
  9. ncbi request reprint [Ten year's experience with combined hepatitis A and B vaccine]
    Jiri Beran
    Centre of vaccination and travel medicine, Hradec Kralove, Czech Republic
    Klin Mikrobiol Infekc Lek 14:13-4, 16-23. 2008
  10. ncbi request reprint [Diabetes mellitus and immunization]
    J Beran
    Klinika infekcních nemocí Lékaské fakulty UK a FN Hradec Králové
    Vnitr Lek 52:438-42. 2006

Collaborators

  • Martina Havlickova
  • Angelika Banzhoff
  • Claudius Malerczyk
  • Elena Fragapane
  • Olaf Zent
  • P Van Damme
  • Stanislav Plisek
  • Ron H Behrens
  • Christoph Hatz
  • Nikolai Mühlberger
  • Tomas Jelinek
  • N Mühlberger
  • K Honegr
  • Ole Wichmann
  • Karel Honegr
  • Urban Hellgren
  • Bernadette Carroll
  • Fabrice Legros
  • Bjørn Myrvang
  • Leo Visser
  • Olivier Bouchaud
  • Heli Siikamaki
  • T Zoller
  • J Gascon
  • U Hellgren
  • I Gjørup
  • H Laferl
  • J Clerinx
  • A Bjorkman
  • M L Holthoff-Stich
  • C Hatz
  • J Gómez i Prat
  • V Lehmann
  • M Schunk
  • J Atouguia
  • R H Behrens
  • Z Bisoffi
  • M H Schulze
  • G Fry
  • S Puente
  • G Soula
  • Z Cermakova
  • J Havlasová
  • V Dostal
  • B Myrvang
  • J Iversen
  • H Siikamaki
  • D Hulinska
  • A Matteelli
  • P McWhinney
  • A Kapaun
  • M L Schmid
  • P Kern
  • H Kollaritsch
  • G Boecken
  • M Probst
  • T Jelinek
  • M Paul
  • S da Cunha
  • R Lopez-Velez
  • D J M Malvy
  • J Knobloch
  • O Bouchaud
  • A Kotlowski
  • Martin P Grobusch
  • Ida Gjørup
  • Peter Kern
  • Gerd Burchard
  • Hermann Laferl
  • Marco Schulze
  • Herwig Kollaritsch
  • Gabriele Peyerl-Hoffmann
  • Saraiva da Cunha
  • Alberto Matteelli
  • Michael Alifrangis
  • Paul McWhinney
  • Joaquim Gascon
  • Juan Cuadros

Detail Information

Publications26

  1. pmc Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
    Jiri Beran
    The Vaccination and Travel Medicine Center, Poliklinika II, Bratri Stefanu 895, Hradec Kralove 500 03, Czech Republic
    BMC Infect Dis 13:224. 2013
    ..Mismatch regularly occurs between the recommended and circulating B-strain. Inclusion of both lineages in vaccines may offer better protection against influenza...
  2. pmc Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop
    N Mühlberger
    Institute of Tropical Medicine, Humboldt University, Berlin, Germany
    Malar J 3:5. 2004
    ..vivax malaria are limited. The TropNetEurop surveillance network has monitored the importation of vivax malaria into Europe since 1999...
  3. pmc The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 6:114. 2007
    ..The risk of adverse events are high and the benefit of avoided benign vivax malaria is very low under current policy, which may be causing more harm than benefit...
  4. pmc Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop
    Ole Wichmann
    Institute of Tropical Medicine, Charite, Humboldt University, Berlin, Germany
    Malar J 2:17. 2003
    ..The objective of this study was to assess the prevalence of this mutation in African isolates of Plasmodium falciparum that have been imported into Europe through travellers...
  5. doi request reprint Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial
    Jiri Beran
    The Vaccination and Travel Medicine Center, University Hospital, 500 03 Hradec Králové, Czech Republic
    J Infect Dis 200:1861-9. 2009
    ..A new trivalent inactivated split-virus influenza vaccine (TIV) was recently introduced in the United States. We assessed the efficacy of TIV against culture-confirmed influenza A and/or B...
  6. pmc Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
    Jiri Beran
    Vaccination and Travel Medicine Centre, Poliklinika II, Hradec Kralove, Czech Republic
    Hum Vaccin 6:578-84. 2010
    ..5 mIU/ml. Local and general symptoms were reported after 80.7% and 45.5% of doses, respectively. However, these were mainly of mild or moderate severity and no subject withdrew from the study due to adverse events...
  7. ncbi request reprint Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients
    Jiri Beran
    School of Medicine and University Hospital, Department of Infectious Diseases, Hradec Kralove, Czech Republic
    Expert Opin Biol Ther 8:235-47. 2008
    ..HBV vaccination is recommended for all patients undergoing dialysis; however, antibody response is much lower than in healthy individuals...
  8. ncbi request reprint [The importance of the second generation adjuvanted systems in "new" vaccines]
    Jiri Beran
    Centre of vaccination and travel medicine, Hradec Kralove, Czech Republic
    Klin Mikrobiol Infekc Lek 14:5-12. 2008
    ..Also for pre-pandemic vaccines is used new generation of adjuvanted systems...
  9. ncbi request reprint [Ten year's experience with combined hepatitis A and B vaccine]
    Jiri Beran
    Centre of vaccination and travel medicine, Hradec Kralove, Czech Republic
    Klin Mikrobiol Infekc Lek 14:13-4, 16-23. 2008
    ..This review is dominantly focused on immunogenicity, safety and reactogenicity data of the vaccine, which are available now for more than 10 years...
  10. ncbi request reprint [Diabetes mellitus and immunization]
    J Beran
    Klinika infekcních nemocí Lékaské fakulty UK a FN Hradec Králové
    Vnitr Lek 52:438-42. 2006
    ..Most often, these are vaccinations against viral hepatitis A, tick-borne encephalitis, meningococcal infections and other infections that put in risk diabetic patients travelling abroad...
  11. pmc Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example
    Jiri Beran
    The Vaccination and Travel Medicine Center, Hradec Kralove, Czech Republic
    BMC Infect Dis 9:2. 2009
    ..Our aim was to determine the efficacy of a trivalent inactivated split virus influenza vaccine (TIV) against culture-confirmed influenza A and/or B in adults 18 to 64 years of age during the 2005/2006 season in the Czech Republic...
  12. ncbi request reprint Safety and immunogenicity of a combined vaccine against hepatitis A and B in patients with autoimmune hepatitis
    J Beran
    Department of Infectious Diseases, University Hospital, Hradec Kralove, Czech Republic
    Cent Eur J Public Health 13:20-3. 2005
    ..One month after the third vaccine dose (month 7), all six vaccinees in the 1-15 years age group developed protective levels of anti-HBs as compared to two of the four vaccinees in the 16+ years age group...
  13. ncbi request reprint Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule
    Jiri Beran
    Vaccination and Travel Medicine Centre, Poliklinika II, Hradec Kralove, Czech Republic
    Int J Med Microbiol 293:130-3. 2004
    ..Long-lasting immunity following this second TBE booster immunization can be concluded...
  14. doi request reprint Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents
    Jiri Beran
    Vaccination and Travel Medicine Centre, Bratri Stefanu 895, 500 03 Hradec Králové, Czech Republic
    Vaccine 28:5993-7. 2010
    ..Hence, with respect to long-term antibody persistence, the two-dose schedule of the combined HAB vaccine Adult formulation is an effective alternative to the conventional three-dose schedule of the Paediatric formulation in adolescents...
  15. ncbi request reprint Effectiveness of vaccination against influenza in SkodaAuto Company employees during the influenza season 2000-2001
    J Beran
    Department of Infectious Diseases, University Hospital, Hradec Kralove, Czech Republic
    Cent Eur J Public Health 11:209-12. 2003
    ..The vaccination effectiveness reached 81.2%...
  16. ncbi request reprint A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults
    Jiri Beran
    Vaccination and Travel Medicine Centre, Poliklinika II, Bratri Stefanu 895, 50003 Hradec Králové, Czech Republic
    Vaccine 21:4650-4. 2003
    ..Vivaxim offers a convenient means of administering both HA and typhoid fever vaccines in subjects already primed for hepatitis A...
  17. pmc Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial
    Jiri Beran
    Vaccination and Travel Medicine Centre, Hradec Kralove, Czech Republic
    BMC Med 7:13. 2009
    ....
  18. doi request reprint Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine
    Jiri Beran
    School of Medicine and University Hospital, Department of Infectious Diseases, Hradec Kralove, Czech Republic
    Expert Rev Vaccines 6:891-902. 2007
    ..This article focuses on immunogenicity of the vaccines and proposes expert opinion and future directions in this field...
  19. ncbi request reprint TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area--impact on current recommendations for immunization of high-risk groups
    Stanislav Plisek
    Department of Infectious Diseases, School of Medicine and University Hospital, Hradec Kralove, Czech Republic
    Vaccine 26:301-4. 2008
    ....
  20. doi request reprint A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
    Jiri Beran
    Vaccination and Travel Medicine Center, Poliklinika II, Hradec Kralove, Czech Republic
    Clin Ther 32:2186-97. 2010
    ..Preparedness for an H5N1 influenza pre-pandemic requires effective and well-tolerated emergency vaccination strategies that provide both pandemic strain-specific and heterologous protection...
  21. ncbi request reprint Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine
    Jiri Beran
    Department of Infectious Diseases, University Hospital, Hradec Kralove, Czech Republic
    Vaccine 23:3902-7. 2005
    ..5 IU/mL by day 14. These results confirm that the current World Health Organization (WHO) recommendations for vaccine potency (2.5 IU per intramuscular dose) are sufficient for use in the Thai Red Cross intradermal regimen...
  22. ncbi request reprint Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety
    Jiri Beran
    Vaccination and Travel Medicine Centre, Poliklinika, Hradec Kralove, Czech Republic
    Vaccine 32:4275-80. 2014
    ..These data lend support to the current belief that subsequent TBE booster intervals could be extended from the current recommendation. NCT00387634. ..
  23. ncbi request reprint Seroprevalence of viral hepatitis A in the Czech Republic
    J Beran
    Purkyne Military Medical Academy, Department of Epidemiology, Hradec Kralove, Czech Republic
    Eur J Epidemiol 15:805-8. 1999
    ..e. the Czech Republic, is a country with a low endemicity for HAV. Substantial parts of the population are or will be at an increased risk of HAV infection and active immunisation against HAV should be considered...
  24. ncbi request reprint The seroprevalence of the "total" anti-HAV antibody in the Czech UNPRO Forces (1991-1995)
    J Beran
    Purkyne Military Medical Academy, Dept of Epidemiology, Hradec Kralove, Czech Republic
    Acta Medica (Hradec Kralove) 39:35-9. 1996
    ..4%-99.0%) in the age cohorts. The results show relatively low seroprevalence of the anti-HAV antibody in all the age cohorts and necessity to vaccinate the Czech UNPROFOR or IFOR units by Havrix before their departure to conflict area...
  25. ncbi request reprint Long term and repeated electron microscopy and PCR detection of Borrelia burgdorferi sensu lato after an antibiotic treatment
    K Honegr
    Department of Infectious Diseases, University Hospital, Hradec Kralove, Czech Republic
    Cent Eur J Public Health 12:6-11. 2004
    ..Also examination of the cerebrospinal fluid with non-specific symptoms and simultaneously displayed pathology electroencephalogram and/or magnetic resonance imaging findings can be advantageous...
  26. ncbi request reprint A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity
    J Beran
    Purkyne Military Medical Academy, Hradec Kralove, Czech Republic
    J Travel Med 7:246-52. 2000
    ..Yet these diseases, which share the same geographic distribution, remain an important cause of morbidity in travelers to endemic countries. Combined vaccination provides dual protection and improves compliance and coverage for travelers...